Prolonged-Release Metformin Tablets Manufacturer & Exporter India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Prolonged-Release Metformin Tablets are specially formulated oral antidiabetic medicines designed to deliver Metformin Hydrochloride in a controlled and extended manner over time. Belonging to the biguanide class, Metformin primarily reduces hepatic glucose output, improves insulin sensitivity, and enhances peripheral glucose uptake without increasing insulin secretion.

The prolonged-release technology ensures gradual drug diffusion, maintaining steady plasma concentrations and minimizing peak-related side effects, especially gastrointestinal discomfort. This makes the formulation particularly suitable for patients requiring consistent glycemic control with improved tolerability and adherence.

Genliva Wellness LLP, Himatnagar, India, is a dependable prolonged release metformin tablet manufacturer India, offering high-quality modified-release antidiabetic formulations for domestic supply, global exports, and third-party manufacturing partnerships.

Prolonged-release metformin tablets are formulated to deliver metformin gradually over time, ensuring steady glycemic control with improved gastrointestinal tolerability. The design supports sustained action suitable for long-term diabetes management.

Extended-release matrix for gradual drug release
Maintains stable blood glucose levels throughout the day
Reduces peaks associated with immediate-release dosing
Improved gastrointestinal tolerability profile
Supports once-daily or reduced-frequency dosing
Engineered for consistent release characteristics

This medication is used for the management of type 2 diabetes mellitus, helping control blood glucose levels and improve metabolic balance.

Type 2 diabetes mellitus management
Control of fasting and postprandial blood glucose
Adjunct to diet and lifestyle modification
Insulin resistance management
Long-term metabolic control therapy

The prolonged-release formulation enhances patient adherence and comfort by providing smooth and sustained drug exposure.

Reduced dosing frequency improves compliance
Lower incidence of gastrointestinal discomfort
Provides steady glycemic control over extended periods
Minimizes fluctuations in blood glucose levels
Suitable for long-term therapy
Consistent performance for routine clinical use